Solara Active Pharma Sciences Limited uploaded the audio recording of its Q1 FY27 earnings call on July 23, 2026, providing investors with access to management’s discussion on unaudited financial results for the quarter ended June 30, 2026. The disclosure ensures transparency and allows stakeholders to review the company’s performance commentary directly.

The conference call was held at 16.00 IST on July 23, 2026. Solara Active Pharma Sciences Limited made the recording available on its website under the Investor Relations section, specifically within Stock Exchange Communication and Investor Update categories. This action complies with regulatory requirements for timely disclosure of material information to shareholders and the broader market.

Regulatory Compliance

The upload was executed pursuant to Regulation 30 and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. These regulations mandate that listed entities disclose material information and provide access to earnings call recordings to ensure equal access for all investors. By adhering to these norms, the company maintains compliance with securities market standards set by the Securities and Exchange Board of India.

Access Details

Investors can access the audio recording via the link provided on the company’s website. The file is hosted directly by Solara Active Pharma Sciences Limited, ensuring authenticity and ease of access. The recording captures the entire session, including questions from analysts and responses from company executives regarding Q1 FY27 performance.

Corporate Governance

Pooja Jaya Kumar, Company Secretary and Compliance Officer of Solara Active Pharma Sciences Limited, signed off on the communication. Her membership number is A57415. The notice was addressed to both the BSE Limited and the National Stock Exchange of India Limited, confirming dual-listing compliance. This procedural step underscores the company’s commitment to governance and regulatory adherence in its investor communications.

Solara Active Pharma Sciences Limited has appointed Mr. Ajit Manocha as its Chief Information Officer (CIO), effective August 10, 2026. The appointment was approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee. Mr. Manocha will form part of the Senior Management Personnel of the company from the aforementioned date.

Mr. Ajit Manocha is a global technology and Life Sciences transformation leader with over 33 years of experience driving digital transformation across pharmaceuticals, CRDMOs, manufacturing, and other regulated industries. His expertise includes aligning technology strategy with business goals, leading enterprise-wide SAP and S/4HANA transformations, and implementing Industry 4.0, IoT, cybersecurity, and AI/ML/Generative AI initiatives.

The disclosure was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that Mr. Manocha has extensive experience working with Boards and senior leadership on technology strategy, cyber risk, and governance, ensuring the protection of intellectual property and data integrity in highly regulated environments.

Appointment Details